Further molecular characterization and stability of the live oral attenuated cholera vaccine strain CVD103-HgR.
Vibrio cholerae CVD103-HgR, the first live attenuated vaccine licensed for human use produced by recombinant DNA technology, was genetically compared to its parent strains 569B and CVD103. The genetic stability for both lyophilized vaccine in final container form and for viable organisms shed from vaccinees was determined. Results obtained lead us to conclude: (i) the genetic composition of the examined genes in CVD103-HgR is identical to that of the parent strains except for the alterations induced; (ii) the level of mercury resistance depends on the orientation of the mer operon within hlyA, with the highest level being observed for the orientation found in CVD103-HgR; (iii) no DNA sequences from plasmids used in construction remain in the genome; (iv) the strain is genetically stable; and (v) both CVD103-HgR and its parent strains contain defective lysogenic prophages. We have further confirmed that a certain amount of restriction fragment length polymorphism (RFLP) exists around the chromosomal ctx locus within V. cholerae strains of the classical biotype (detectable on chromosomal DNA restricted by either HindIII or EcoRI, but not PstI).
Favre
D
D
Swiss Serum and Vaccine Institute, Berne, Switzerland.
Struck
M M
MM
Cryz
S J
SJ
Viret
J F
JF
D001428:Bacterial Vaccines / Q000235:genetics* / Q000276:immunology*; D001435:Bacteriophages / Q000302:isolation & purification; D004352:Drug Resistance, Microbial; D004355:Drug Stability; D006801:Humans; D008628:Mercury / Q000633:toxicity; D013045:Species Specificity; D014613:Vaccines, Attenuated / Q000235:genetics / Q000276:immunology; D014734:Vibrio cholerae / Q000187:drug effects / Q000235:genetics* / Q000276:immunology* / Q000821:virology
D001428:Bacterial Vaccines; D014613:Vaccines, Attenuated; D008628:Mercury